Align Technology, Inc. Stock

Equities

ALGN

US0162551016

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-04-19 pm EDT 5-day change 1st Jan Change
299 USD -0.78% Intraday chart for Align Technology, Inc. -5.08% +9.12%
Sales 2024 * 4.05B Sales 2025 * 4.46B Capitalization 22.5B
Net income 2024 * 541M Net income 2025 * 624M EV / Sales 2024 * 5.22 x
Net cash position 2024 * 1.36B Net cash position 2025 * 1.54B EV / Sales 2025 * 4.71 x
P/E ratio 2024 *
41.7 x
P/E ratio 2025 *
35.8 x
Employees 21,610
Yield 2024 *
-
Yield 2025 *
-
Free-Float 93.46%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.78%
1 week-5.08%
Current month-8.83%
1 month-5.74%
3 months+12.26%
6 months+10.61%
Current year+9.12%
More quotes
1 week
296.50
Extreme 296.5
319.81
1 month
296.50
Extreme 296.5
335.40
Current year
250.28
Extreme 250.28
335.40
1 year
176.34
Extreme 176.34
413.20
3 years
172.05
Extreme 172.05
737.45
5 years
127.88
Extreme 127.88
737.45
10 years
43.27
Extreme 43.27
737.45
More quotes
Managers TitleAgeSince
Chief Executive Officer 65 15-05-31
Director of Finance/CFO 57 16-11-09
Chief Tech/Sci/R&D Officer 59 13-12-01
Members of the board TitleAgeSince
Director/Board Member 72 06-01-31
Chief Executive Officer 65 15-05-31
Director/Board Member 58 Dec. 04
More insiders
Date Price Change Volume
24-04-19 299 -0.78% 520,396
24-04-18 301.3 +0.40% 417,217
24-04-17 300.1 -1.63% 574,960
24-04-16 305.1 +0.12% 502,777
24-04-15 304.7 -3.25% 549,893

Delayed Quote Nasdaq, April 19, 2024 at 04:00 pm EDT

More quotes
Align Technology, Inc. specializes in the design, manufacturing and marketing of dental and medical devices. Net sales break down by family of products as follows: - clear aligners (82.8%): sold under the brand name Invisalign; - intra-oral scanners (17.2%): iTero. The group also offers scanner services. Net sales are distributed geographically as follows: the United States (43.1%), Switzerland (30.3%), and other (26.6%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
299 USD
Average target price
321 USD
Spread / Average Target
+7.35%
Consensus